Patents by Inventor David H. Fine

David H. Fine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11243197
    Abstract: A device and method for calibrating a NO delivery device using NO and NO2 measurements, without using a known standard.
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: February 8, 2022
    Assignee: VERO Biotech LLC
    Inventors: David H. Fine, Edward Bromberg, Thorsten Schmidt, Ryan Denton
  • Publication number: 20220016379
    Abstract: A method and device can alternately deliver high concentration of nitric oxide and oxygen-enriched air.
    Type: Application
    Filed: March 29, 2021
    Publication date: January 20, 2022
    Applicant: VERO Biotech LLC
    Inventors: David H. FINE, Lee LEICHTER
  • Publication number: 20220008679
    Abstract: Various systems and devices for generating nitric oxide are disclosed herein. According to one embodiment, the device includes a body having an inlet, an outlet, and a porous solid matrix positioned with the body. The porous solid matrix is coated with an aqueous solution of an antioxidant, wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide. The porous solid matrix allows the device to be used in any orientation. Additionally, the porous solid matrix provides a rigid structure suitable to withstand vibrations and abuse without compromising device functionality.
    Type: Application
    Filed: February 22, 2021
    Publication date: January 13, 2022
    Applicant: VERO Biotech LLC
    Inventors: David H. FINE, Bryan JOHNSON, Gregory VASQUEZ
  • Patent number: 11208326
    Abstract: Dinitrogen tetroxide (N2O4) is synthesized in an apparatus by the reaction of concentrated nitric acid with copper. Oxygen is applied as a carrier gas to convert NO to NO2, and water vapor is removed with a tube dryer. A molecular sieve is applied to reduce and remove impurities.
    Type: Grant
    Filed: July 18, 2019
    Date of Patent: December 28, 2021
    Assignee: VERO Biotech LLC
    Inventors: David H. Fine, Thorsten Schmidt, Bryan Johnson, Alessandra Miranda, Edward Bromberg, Marjorie Nelson
  • Publication number: 20210393915
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
    Type: Application
    Filed: August 27, 2021
    Publication date: December 23, 2021
    Applicant: VERO Biotech LLC
    Inventors: David P. ROUNBEHLER, David H. FINE
  • Patent number: 11202880
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
    Type: Grant
    Filed: October 26, 2020
    Date of Patent: December 21, 2021
    Assignee: VERO Biotech LLC
    Inventors: David P. Rounbehler, David H. Fine
  • Publication number: 20210386958
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
    Type: Application
    Filed: August 27, 2021
    Publication date: December 16, 2021
    Applicant: VERO Biotech LLC
    Inventors: David P. ROUNBEHLER, David H. FINE
  • Patent number: 11154210
    Abstract: A method for treating pulmonary arterial hypertension in a patient can include determining whether a patient with pulmonary arterial hypertension has an enlarged right ventricle or right ventricular dysfunction, where the patient has previously been administered a prostanoid and weaning the patient off of the prostanoid if the patient does not have an enlarged right ventricle or right ventricular dysfunction.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: October 26, 2021
    Assignee: VERO Biotech LLC
    Inventors: Tammy Watts, Robert F. Roscigno, David H. Fine, Lewis J. Rubin
  • Publication number: 20210316107
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
    Type: Application
    Filed: October 26, 2020
    Publication date: October 14, 2021
    Applicant: VERO Biotech LLC
    Inventors: David P. ROUNBEHLER, David H. FINE
  • Patent number: 11103669
    Abstract: A method for delivering nitric oxide therapy to a subject can include administering a composition including a nitric-oxide releasing agent and silica to the subject and releasing a therapeutic amount of nitric oxide from the composition.
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: August 31, 2021
    Assignee: Vero Biotech LLC
    Inventor: David H. Fine
  • Patent number: 11000484
    Abstract: Various methods for diagnosing and treating heart conditions are disclosed herein. According to one method, nitric oxide is delivered to a patient's lungs when the patient has one or more symptoms of a heart condition. The patient is diagnosed as suffering from a heart condition when a symptom of a heart condition subsides after nitric oxide delivery.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: May 11, 2021
    Assignee: Vero Biotech LLC
    Inventor: David H. Fine
  • Publication number: 20210100972
    Abstract: A device and method for treating high-altitude sickness can include a handheld device, and can deliver a therapeutic amount of nitric oxide to an individual's lungs in order to minimize or treat high-altitude sickness. The device is self-contained and portable, which allows an individual to carry and use the device in high-altitude or other low-oxygen environments.
    Type: Application
    Filed: September 18, 2020
    Publication date: April 8, 2021
    Applicant: VERO Biotech LLC
    Inventors: David H. FINE, Gregory VASQUEZ, Bryan JOHNSON
  • Patent number: 10960168
    Abstract: A method and device can alternately deliver high concentration of nitric oxide and oxygen-enriched air. A method of providing a therapeutic amount of nitric oxide to a mammal can include delivering one or more breaths of a therapeutic amount of nitric oxide to the mammal and delivering one or more breaths of an amount of oxygen-enriched air to the mammal immediately after the one or more breaths of the therapeutic amount of nitric oxide.
    Type: Grant
    Filed: August 13, 2009
    Date of Patent: March 30, 2021
    Assignee: VERO Biotech LLC
    Inventors: David H. Fine, Lee Leichter
  • Patent number: 10926054
    Abstract: Various systems and devices for generating nitric oxide are disclosed herein. According to one embodiment, the device includes a body having an inlet, an outlet, and a porous solid matrix positioned with the body. The porous solid matrix is coated with an aqueous solution of an antioxidant, wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide. The porous solid matrix allows the device to be used in any orientation. Additionally, the porous solid matrix provides a rigid structure suitable to withstand vibrations and abuse without compromising device functionality.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: February 23, 2021
    Assignee: Vero Biotech LLC
    Inventors: David H. Fine, Bryan Johnson, Gregory Vasquez
  • Publication number: 20200368271
    Abstract: A method of modulating oxygen saturation levels can include measuring oxygen saturation levels in a patient, administering inhaled nitric oxide, adjusting the dose of oxygen in real time to a second dose based on the inhaled nitric oxide.
    Type: Application
    Filed: January 27, 2020
    Publication date: November 26, 2020
    Inventors: Kurt A. DASSE, Priscilla C. PETIT, David H. FINE, Mark K. WEDEL
  • Patent number: 10814092
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
    Type: Grant
    Filed: November 12, 2018
    Date of Patent: October 27, 2020
    Assignee: VERO Biotech LLC
    Inventors: David P. Rounbehler, David H. Fine
  • Publication number: 20200282375
    Abstract: A nitric oxide delivery system, which includes a gas bottle having nitrogen dioxide in air, converts nitrogen dioxide to nitric oxide and employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid. A nitric oxide delivery system may be used to generate therapeutic gas including nitric oxide for use in delivering the therapeutic gas to a mammal.
    Type: Application
    Filed: October 1, 2019
    Publication date: September 10, 2020
    Inventors: David H. FINE, David P. ROUNBEHLER, Gregory VASQUEZ, Bryan JOHNSON
  • Publication number: 20200180958
    Abstract: Various systems, devices, NO2 absorbents, NO2 scavengers and NO2 recuperator for generating nitric oxide are disclosed herein. According to one embodiment, an apparatus for converting nitrogen dioxide to nitric oxide can include a receptacle including an inlet, an outlet, a surface-active material coated with an aqueous solution of ascorbic acid and an absorbent wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the surface-active material and the absorbent such that nitrogen dioxide in the gas flow is converted to nitric oxide.
    Type: Application
    Filed: July 15, 2019
    Publication date: June 11, 2020
    Applicant: VERO Biotech LLC
    Inventors: David H. FINE, Gregory VASQUEZ, David P. ROUNBEHLER
  • Publication number: 20200139071
    Abstract: Various systems generating nitric oxide are disclosed herein. According to one embodiment, the system includes a first gas source providing nitrogen dioxide mixed in air or oxygen, and a second gas source supplying compressed air and/or compressed oxygen. The system also includes a ventilator coupled to the first and second gas sources, wherein the ventilator is resistant to nitrogen dioxide. The ventilator regulates gas flow and allows for the adjustment of nitrogen dioxide concentration in the gas flow. The system further includes one or more conversion devices operably coupled to the ventilator where the conversion devices convert nitrogen dioxide into nitric oxide. A patient interface delivers nitric oxide to the patient and is operably coupled to the conversion devices. The system allows oxygen and nitric oxide levels to be varied independently.
    Type: Application
    Filed: June 18, 2019
    Publication date: May 7, 2020
    Applicant: VERO Biotech LLC
    Inventors: David H. FINE, Bryan JOHNSON, Gregory VASQUEZ
  • Publication number: 20200139073
    Abstract: Various systems generating nitric oxide are disclosed herein. According to one embodiment, the system includes a first gas source providing nitrogen dioxide mixed in air or oxygen, and a second gas source supplying compressed air and/or compressed oxygen. The system also includes a ventilator coupled to the first and second gas sources, wherein the ventilator is resistant to nitrogen dioxide. The ventilator regulates gas flow and allows for the adjustment of nitrogen dioxide concentration in the gas flow. The system further includes one or more conversion devices operably coupled to the ventilator where the conversion devices convert nitrogen dioxide into nitric oxide. A patient interface delivers nitric oxide to the patient and is operably coupled to the conversion devices. The system allows oxygen and nitric oxide levels to be varied independently.
    Type: Application
    Filed: June 20, 2019
    Publication date: May 7, 2020
    Applicant: VERO Biotech LLC
    Inventors: Alfred TECTOR, Priscilla C. PETIT, Kurt A. DASSE, David H. FINE